Language selection

Search

Details for: RISPERDAL CONSTA

Company: JANSSEN INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02298465RISPERDAL CONSTARISPERIDONE12.5 MG / VIALPOWDER FOR SUSPENSION, SUSTAINED-RELEASEINTRAMUSCULAR
02298465RISPERDAL CONSTARISPERIDONE12.5 MG / VIALKITINTRAMUSCULAR
02255707RISPERDAL CONSTARISPERIDONE25 MG / VIALKITINTRAMUSCULAR
02255707RISPERDAL CONSTARISPERIDONE25 MG / VIALPOWDER FOR SUSPENSION, SUSTAINED-RELEASEINTRAMUSCULAR
02255723RISPERDAL CONSTARISPERIDONE37.5 MG / VIALPOWDER FOR SUSPENSION, SUSTAINED-RELEASEINTRAMUSCULAR
02255723RISPERDAL CONSTARISPERIDONE37.5 MG / VIALKITINTRAMUSCULAR
02255758RISPERDAL CONSTARISPERIDONE50 MG / VIALKITINTRAMUSCULAR
02255758RISPERDAL CONSTARISPERIDONE50 MG / VIALPOWDER FOR SUSPENSION, SUSTAINED-RELEASEINTRAMUSCULAR
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of sleep walking and sleep-related eating disorder
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: